Madhuri Vusirikala

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti–T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease–Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

Robert J. Soiffer, Haesook T. Kim, Joseph P. McGuirk et al. · Journal of Clinical Oncology · 2017 · 304 citations · Full text

Cell Therapy, Gvhd Prophylaxis, Immunology +17

Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Patrick A. Brown, Bijal Shah, Anjali S. Advani et al. · Journal of the National Comprehensive Cancer Network · 2021 · 230 citations · Full text

Hematological Malignancy, Nccn All Panel, Medicine +15

Crenolanib besylate, a type I pan-FLT3 inhibitor, to demonstrate clinical activity in multiply relapsed FLT3-ITD and D835 AML.

Jörge E. Cortes, Hagop M. Kantarjian, Tapan M. Kadia et al. · Journal of Clinical Oncology · 2016 · 101 citations

Mixed-phenotype Acute Leukemia, Pharmacotherapy, D835 Aml +20

Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (VMAT-TBI): Six-year Clinical Experience and Treatment Outcomes

Elizabeth Zhang-Velten, David Parsons, Pam Lee et al. · Transplantation and Cellular Therapy · 2021 · 35 citations

Hematogone Hyperplasia in Copper Deficiency

Lisa Sutton, Madhuri Vusirikala, Weina Chen · American Journal of Clinical Pathology · 2009 · 25 citations · Full text

Low-grade Mds, Bone Marrow Failure, Iron Metabolism +11